List of Schedule 1 Drugs
Schedule I drugs are those that have the following characteristic according to the United States Drug Enforcement Agency (DEA):
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical treatment use in the U.S.
- It has a lack of accepted safety for use under medical supervision.
According to federal law, no prescriptions may be written for Schedule I substances, and they are not readily available for clinical use.
A substance does not need to be listed as a controlled substance by the DEA to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue (for example, a “designer drug”) is a substance which is structurally or pharmacologically similar to a Schedule I or Schedule II substance, specifically used for human consumption, and is not an approved medication in the United States.
Drugs or Substances listed in DEA Schedule I may include:
LSD (Lysergic acid diethylamide)
Marijuana (cannabis, THC)
MDMA (3,4-methylenedioxymethamphetamine or “ecstasy”)
GHB (gamma-hydroxybutyric acid) – except formulations in an FDA-approved drug product sodium oxybate (Xyrem) are Schedule III
Ecstasy (MDMA or 3,4-Methylenedioxymethamphetamine)
Psilocybin (“magic mushrooms”)
Synthetic marijuana and analogs (Spice, K2)
Khat (Cathinone, Cathine)
Bath Salts (3,4-methylenedioxypyrovalerone or MDPV)
- The Controlled Substances Act (CSA) schedule information displayed above applies to drugs or substances regulated under federal law. There may be variations in CSA schedules between individual states and federal law. For example, some drugs or compounds may be deemed a schedule I drug or may be listed in a different schedule in a state’s specific controlled substance act, which may differ from the federal controlled substance act.